Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling

Alzheimer's disease (AD) is a devastating, incurable neurodegenerative disease affecting millions of people worldwide. Dysregulation of intracellular Ca(2+) signaling has been observed as an early event prior to the presence of clinical symptoms of AD and is believed to be a crucial factor contributing to its pathogenesis. The progressive and sustaining increase in the resting level of cytosolic Ca(2+) will affect downstream activities and neural functions. This review focuses on the issues relating to the increasing Ca(2+) release from the endoplasmic reticulum (ER) observed in AD neurons. Numerous research papers have suggested that the dysregulation of ER Ca(2+) homeostasis is associated with mutations in the presenilin genes and amyloid-β oligomers. These disturbances could happen at many different points in the signaling process, directly affecting ER Ca(2+) channels or interfering with related pathways, which makes it harder to reveal the underlying mechanisms. This review paper also shows that computational modeling is a powerful tool in Ca(2+) signaling studies and discusses the progress in modeling related to Ca(2+) dysregulation in AD research.

[1]  M Segal,et al.  Geometry of dendritic spines affects calcium dynamics in hippocampal neurons: theory and experiments. , 1999, Journal of neurophysiology.

[2]  D. Kang,et al.  Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels* , 2012, The Journal of Biological Chemistry.

[3]  M. Rahgozar,et al.  Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population , 2010, Avicenna journal of medical biotechnology.

[4]  W. Lederer,et al.  Models of Ca2+ release channel adaptation. , 1995, Science.

[5]  Grace E Stutzmann,et al.  Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability , 2004, The Journal of Neuroscience.

[6]  J. Rinzel,et al.  Equations for InsP3 receptor-mediated [Ca2+]i oscillations derived from a detailed kinetic model: a Hodgkin-Huxley like formalism. , 1994, Journal of theoretical biology.

[7]  S. Feske,et al.  Reduced Synaptic STIM2 Expression and Impaired Store-Operated Calcium Entry Cause Destabilization of Mature Spines in Mutant Presenilin Mice , 2014, Neuron.

[8]  E. Posse de Chaves,et al.  Aβ Internalization by Neurons and Glia , 2011, International journal of Alzheimer's disease.

[9]  M. Berridge,et al.  Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature reviews. Molecular cell biology.

[10]  R. J. Kelleher,et al.  The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.

[11]  M. Mattson,et al.  Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.

[12]  Alexei Verkhratsky,et al.  Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. , 2005, Physiological reviews.

[13]  J. Fastbom,et al.  Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies , 1999, Neuroscience.

[14]  B. Winblad,et al.  Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology , 1998, Brain Research.

[15]  B. de Strooper,et al.  Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore* , 2011, The Journal of Biological Chemistry.

[16]  Carson C. Chow,et al.  Calcium time course as a signal for spike-timing-dependent plasticity. , 2005, Journal of neurophysiology.

[17]  Paul D Allen,et al.  Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes. , 2004, The Journal of biological chemistry.

[18]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[19]  R. Sadoul,et al.  Emerging Role of Neuronal Exosomes in the Central Nervous System , 2012, Front. Physio..

[20]  J. Foskett,et al.  Regulation by Ca2+ and Inositol 1,4,5-Trisphosphate (Insp3) of Single Recombinant Type 3 Insp3 Receptor Channels , 2001, The Journal of general physiology.

[21]  F. Pasquier,et al.  A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.

[22]  M. Mattson,et al.  Presenilin-1 Mutation Increases Neuronal Vulnerability to Focal Ischemia In Vivo and to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis , 2000, The Journal of Neuroscience.

[23]  J. Bradley,et al.  Up‐regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer’s disease , 2010, Journal of neurochemistry.

[24]  F. LaFerla,et al.  Enhanced Ryanodine‐Mediated Calcium Release in Mutant PS1‐Expressing Alzheimer's Mouse Models , 2007, Annals of the New York Academy of Sciences.

[25]  Don-On Daniel Mak,et al.  Inositol trisphosphate receptor Ca2+ release channels. , 2007, Physiological reviews.

[26]  W. Levy,et al.  Insights into associative long-term potentiation from computational models of NMDA receptor-mediated calcium influx and intracellular calcium concentration changes. , 1990, Journal of neurophysiology.

[27]  P. Verkade,et al.  Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  I. Bezprozvanny,et al.  Theoretical analysis of calcium wave propagation based on inositol (1,4,5)-trisphosphate (InsP3) receptor functional properties. , 1994, Cell calcium.

[29]  F. LaFerla,et al.  A dynamic relationship between intracellular and extracellular pools of Abeta. , 2006, The American journal of pathology.

[30]  T. Pozzan,et al.  Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake , 2009, Journal of cellular and molecular medicine.

[31]  David B. Sattelle,et al.  The effects of amyloid peptides on A-type K+ currents of Drosophila larval cholinergic neurons: modeled actions on firing properties , 2006, Invertebrate Neuroscience.

[32]  Samuel Bandara,et al.  Regulators of Calcium Homeostasis Identified by Inference of Kinetic Model Parameters from Live Single Cells Perturbed by siRNA , 2013, Science Signaling.

[33]  M. Behrens,et al.  Redox regulation of RyR-mediated Ca2+ release in muscle and neurons. , 2004, Biological research.

[34]  C. Cotman,et al.  Alzheimer's Presenilin‐1 Mutation Potentiates Inositol 1,4,5‐Trisphosphate‐Mediated Calcium Signaling in Xenopus , 1999, Journal of neurochemistry.

[35]  Zaven S. Khachaturian,et al.  Hypothesis on the Regulation of Cytosol Calcium Concentration and the Aging Brain , 1987, Neurobiology of Aging.

[36]  T. Iwatsubo,et al.  Gain-of-Function Enhancement of IP3 Receptor Modal Gating by Familial Alzheimer’s Disease–Linked Presenilin Mutants in Human Cells and Mouse Neurons , 2010, Science Signaling.

[37]  I. Bezprozvanny The inositol 1,4,5-trisphosphate receptors. , 2005, Cell calcium.

[38]  M. Bootman,et al.  Alzheimer's disease-associated peptide Aβ42 mobilizes ER Ca2+ via InsP3R-dependent and -independent mechanisms , 2013, Front. Mol. Neurosci..

[39]  Ivan V. Goussakov,et al.  NMDA-Mediated Ca2+ Influx Drives Aberrant Ryanodine Receptor Activation in Dendrites of Young Alzheimer's Disease Mice , 2010, The Journal of Neuroscience.

[40]  M. Madesh,et al.  STIM proteins: dynamic calcium signal transducers , 2012, Nature Reviews Molecular Cell Biology.

[41]  D. Rujescu,et al.  CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s Disease , 2011, Molecular medicine.

[42]  E. Schon,et al.  Upregulated function of mitochondria-associated ER membranes in Alzheimer disease , 2012, The EMBO journal.

[43]  S. Duckles,et al.  Calcium Regulation in Neuronal Function with Advancing Age: Limits of Homeostasis , 2012 .

[44]  C. Hidalgo,et al.  Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation , 2011, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. García-Sancho,et al.  Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress. , 2011, The Biochemical journal.

[46]  F. LaFerla,et al.  Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice , 2008, Journal of neurochemistry.

[47]  C. Oliveira,et al.  An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity , 2006, Neurobiology of Disease.

[48]  W. Xu,et al.  CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population. , 2010, Journal of Alzheimer's disease : JAD.

[49]  P. Dodd,et al.  Synaptic Degeneration in Alzheimer's Disease , 2011 .

[50]  Hyoung-Gon Lee,et al.  Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide , 2009, Brain Research.

[51]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[52]  Martin Falcke,et al.  Clustering of IP3 receptors by IP3 retunes their regulation by IP3 and Ca2+ , 2009, Nature.

[53]  A. Goate,et al.  Presenilin function and γ‐secretase activity , 2005, Journal of Neurochemistry.

[54]  Paolo Zamboni,et al.  Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.

[55]  K. Hensley,et al.  Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.

[56]  E. Schon,et al.  Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. , 2009, The American journal of pathology.

[57]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[58]  P. Bosco,et al.  The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. , 2010, Journal of Alzheimer's disease : JAD.

[59]  Rui Alves,et al.  Tools for kinetic modeling of biochemical networks , 2006, Nature Biotechnology.

[60]  J. Shine,et al.  Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium* , 2006, Journal of Biological Chemistry.

[61]  T. Ozaki,et al.  Quantifying the uncertainty of spontaneous Ca2+ oscillations in astrocytes: particulars of Alzheimer's disease. , 2011, Biophysical journal.

[62]  J. Sneyd,et al.  Models of the inositol trisphosphate receptor. , 2005, Progress in biophysics and molecular biology.

[63]  J. Kuźnicki,et al.  Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease. , 2009, Biochimica et biophysica acta.

[64]  Junichiro Yoshimoto,et al.  A model-based prediction of the calcium responses in the striatal synaptic spines depending on the timing of cortical and dopaminergic inputs and post-synaptic spikes , 2013, Front. Comput. Neurosci..

[65]  Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[66]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[67]  G. Augustine How does calcium trigger neurotransmitter release? , 2001, Current Opinion in Neurobiology.

[68]  D. Selkoe,et al.  Caffeine stimulates amyloid beta-peptide release from beta-amyloid precursor protein-transfected HEK293 cells. , 1997, Journal of neurochemistry.

[69]  P. Allen,et al.  Calcium Dyshomeostasis in β-Amyloid and Tau-bearing Skeletal Myotubes* , 2004, Journal of Biological Chemistry.

[70]  S. DeKosky,et al.  No association between CALHM1 variation and risk of Alzheimer disease , 2009, Human mutation.

[71]  L. Missiaen,et al.  Molecular physiology of the SERCA and SPCA pumps. , 2002, Cell calcium.

[72]  J. Keizer,et al.  Ryanodine receptor adaptation and Ca2+(-)induced Ca2+ release-dependent Ca2+ oscillations. , 1996, Biophysical journal.

[73]  Steven Sheng-Shih Wang,et al.  A Kinetic Analysis of the Mechanism of β-Amyloid Induced G Protein Activation , 2003 .

[74]  D Holcman,et al.  Calcium dynamics in dendritic spines and spine motility. , 2004, Biophysical journal.

[75]  E. Schon,et al.  Mitochondria-associated ER membranes in Alzheimer disease , 2013, Molecular and Cellular Neuroscience.

[76]  P. Greengard,et al.  Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.

[77]  J. García-Sancho,et al.  The sarco/endoplasmic reticulum Ca(2+) ATPase (SERCA) is the third element in capacitative calcium entry. , 2010, Cell calcium.

[78]  D. Selkoe,et al.  Calcium ionophore increases amyloid beta peptide production by cultured cells. , 1994, Biochemistry.

[79]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[80]  Tricia A. Thornton-Wells,et al.  Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography , 2013, Human Genetics.

[81]  Olivier Thibault,et al.  Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store , 2007, Aging cell.

[82]  Ian Parker,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. , 2008, The Journal of general physiology.

[83]  M. Mattson,et al.  Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.

[84]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[85]  C. Oliveira,et al.  Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5‐triphosphate receptors in the neurotoxic effects induced by the amyloid‐β peptide , 2004, Journal of neuroscience research.

[86]  Mark P Mattson,et al.  Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders , 2000, Trends in Neurosciences.

[87]  O. Maes,et al.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders , 2009, Current genomics.

[88]  Natasha P Wilson,et al.  Modeling the short time-scale dynamics of β-amyloid-neuron interactions. , 2013, Journal of theoretical biology.

[89]  E. Lea,et al.  Kinetic model of the inositol trisphosphate receptor that shows both steady-state and quantal patterns of Ca2+ release from intracellular stores. , 2003, The Biochemical journal.

[90]  A. Ruiz,et al.  CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. , 2010, Journal of Alzheimer's disease : JAD.

[91]  C. Ghelardini,et al.  A gene‐specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant‐like effect in mice , 2008, Journal of neurochemistry.

[92]  Daniel L. Rubin,et al.  Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease , 2008, PLoS Comput. Biol..

[93]  W. Thies,et al.  2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.

[94]  Shaomin Li,et al.  Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.

[95]  J. Molgó,et al.  Early Presynaptic and Postsynaptic Calcium Signaling Abnormalities Mask Underlying Synaptic Depression in Presymptomatic Alzheimer's Disease Mice , 2012, The Journal of Neuroscience.

[96]  R. Sitsapesan,et al.  Markovian models of low and high activity levels of cardiac ryanodine receptors. , 2001, Biophysical journal.

[97]  A. Vortmeyer,et al.  Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein , 2013, Neuron.

[98]  J. Sneyd,et al.  Calcium wave propagation by calcium-induced calcium release: an unusual excitable system. , 1993, Bulletin of mathematical biology.

[99]  D. Selkoe,et al.  Caffeine Stimulates Amyloid β‐Peptide Release from β‐Amyloid Precursor Protein‐Transfected HEK293 Cells , 1997 .

[100]  J. Kotaleski,et al.  Modeling The Dynamics of Second Messenger Pathways , 2003 .

[101]  E. Kandel,et al.  Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.

[102]  Michael J. Berridge,et al.  Calcium hypothesis of Alzheimer’s disease , 2010, Pflügers Archiv - European Journal of Physiology.

[103]  Yigong Shi,et al.  Structure of a presenilin family intramembrane aspartate protease , 2012, Nature.

[104]  Vivien Kirk,et al.  A bifurcation analysis of calcium buffering. , 2006, Journal of theoretical biology.

[105]  S. Schuster,et al.  Modelling of simple and complex calcium oscillations , 2002 .

[106]  Klaus-Peter Lesch,et al.  Epigenetically regulated microRNAs in Alzheimer's disease , 2014, Neurobiology of Aging.

[107]  K. Oka,et al.  Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[108]  V. Lee,et al.  Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating , 2008, Neuron.

[109]  F. Diederichs Ion homeostasis and the functional roles of SERCA reactions in stimulus-secretion coupling of the pancreatic beta-cell: A mathematical simulation. , 2008, Biophysical chemistry.

[110]  S. Schuster,et al.  Modelling of simple and complex calcium oscillations. From single-cell responses to intercellular signalling. , 2002, European journal of biochemistry.

[111]  J L van Hemmen,et al.  Intracellular Ca2+ stores can account for the time course of LTP induction: a model of Ca2+ dynamics in dendritic spines. , 1995, Journal of neurophysiology.

[112]  T. Good,et al.  Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. Schapansky,et al.  NF-κB activated by ER calcium release inhibits Aβ-mediated expression of CHOP protein: Enhancement by AD-linked mutant presenilin 1 , 2007, Experimental Neurology.

[114]  G. Voeltz,et al.  Endoplasmic reticulum–mitochondria contacts: function of the junction , 2012, Nature Reviews Molecular Cell Biology.

[115]  F. Benfenati,et al.  Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease , 2012, The Journal of Neuroscience.

[116]  A Goldbeter,et al.  Minimal model for signal-induced Ca2+ oscillations and for their frequency encoding through protein phosphorylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[117]  F. LaFerla,et al.  SERCA pump activity is physiologically regulated by presenilin and regulates amyloid β production , 2008, The Journal of cell biology.

[118]  M. Berridge Calcium regulation of neural rhythms, memory and Alzheimer's disease , 2014, The Journal of physiology.

[119]  R. Cowburn,et al.  β-amyloid peptides enhance binding of the calcium mobilising second messengers, inositol(1,4,5)trisphosphate and inositol-(1,3,4,5)tetrakisphosphate to their receptor sites in rat cortical membranes , 1995, Neuroscience Letters.

[120]  Adriana B Ferreira,et al.  β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons* , 2006, Journal of Biological Chemistry.

[121]  Yi Zhao,et al.  CALHM1 variant is not associated with Alzheimer's disease among Asians , 2011, Neurobiology of Aging.

[122]  J. Richardson,et al.  Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease , 2012, PloS one.

[123]  L. Loew,et al.  An image-based model of calcium waves in differentiated neuroblastoma cells. , 2000, Biophysical journal.

[124]  M. Mattson,et al.  Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.

[125]  H. Kretzschmar,et al.  Capacitive Calcium Entry Is Directly Attenuated by Mutant Presenilin-1, Independent of the Expression of the Amyloid Precursor Protein* , 2003, The Journal of Biological Chemistry.

[126]  S. Sensi,et al.  New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc , 2011, Cell Death and Disease.

[127]  S. Rombouts,et al.  Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity , 2010, PloS one.

[128]  S. Wagner,et al.  Ca2+ Influx through Store-operated Ca2+ Channels Reduces Alzheimer Disease β-Amyloid Peptide Secretion* , 2013, The Journal of Biological Chemistry.

[129]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[130]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[131]  James Sneyd,et al.  A buffering SERCA pump in models of calcium dynamics. , 2006, Biophysical journal.

[132]  M. Schuldiner,et al.  Staying in touch: the molecular era of organelle contact sites. , 2011, Trends in biochemical sciences.

[133]  B. de Strooper,et al.  Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. , 2012, Cold Spring Harbor perspectives in medicine.

[134]  I. Bezprozvanny,et al.  Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis. , 2011, Cell calcium.

[135]  I. Bezprozvanny,et al.  The dysregulation of intracellular calcium in Alzheimer disease. , 2010, Cell calcium.

[136]  J. Kuźnicki,et al.  Calcium dysregulation in Alzheimer's disease , 2008, Neurochemistry International.

[137]  C. Ward,et al.  Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle , 2010, Neurobiology of Aging.

[138]  Y. Auberson,et al.  Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. , 2012, Cell Calcium.

[139]  R. J. McDonald,et al.  Revisiting the cholinergic hypothesis in the development of Alzheimer's disease , 2011, Neuroscience & Biobehavioral Reviews.

[140]  J. Foskett,et al.  Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling. , 2011, Antioxidants & redox signaling.

[141]  Z. Khachaturian,et al.  Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.

[142]  J. Sneyd,et al.  Agonist-dependent Phosphorylation of the Inositol 1,4,5-Trisphosphate Receptor , 1999, The Journal of general physiology.

[143]  Z. Khachaturian Calcium Hypothesis of Alzheimer's Disease and Brain Aging a , 1994, Annals of the New York Academy of Sciences.

[144]  M. Berridge Elementary and global aspects of calcium signalling. , 1997, The Journal of physiology.

[145]  I. Grundke‐Iqbal,et al.  Tau pathology in Alzheimer disease and other tauopathies. , 2005, Biochimica et biophysica acta.

[146]  Satoshi Matsuoka,et al.  Role of individual ionic current systems in ventricular cells hypothesized by a model study. , 2003, The Japanese journal of physiology.

[147]  Miles W. Miller,et al.  Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.

[148]  T. Pozzan,et al.  Intracellular Calcium Oscillations in Astrocytes: A Highly Plastic, Bidirectional Form of Communication between Neurons and Astrocytes In Situ , 1997, The Journal of Neuroscience.

[149]  L. Goldstein,et al.  Alzheimer's disease in a dish: promises and challenges of human stem cell models. , 2012, Human molecular genetics.

[150]  Thomas M. Morse,et al.  Abnormal Excitability of Oblique Dendrites Implicated in Early Alzheimer's: A Computational Study , 2009, Frontiers in neural circuits.

[151]  M. Kawahara,et al.  Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein , 2011, International journal of Alzheimer's disease.

[152]  B. Strooper,et al.  Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.

[153]  Frank M LaFerla,et al.  Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. , 2005, Cell calcium.

[154]  G. Bett,et al.  Computer model of action potential of mouse ventricular myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.

[155]  B. Winblad,et al.  Modulation of the endoplasmic reticulum–mitochondria interface in Alzheimer’s disease and related models , 2013, Proceedings of the National Academy of Sciences.

[156]  K. T. Blackwell,et al.  Approaches and tools for modeling signaling pathways and calcium dynamics in neurons , 2013, Journal of Neuroscience Methods.

[157]  I. Parker,et al.  Cytotoxicity of Intracellular Aβ42 Amyloid Oligomers Involves Ca2+ Release from the Endoplasmic Reticulum by Stimulated Production of Inositol Trisphosphate , 2013, The Journal of Neuroscience.

[158]  G. Binetti,et al.  Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease , 2011, Neurobiology of Aging.

[159]  S. Hébert,et al.  Up-regulation of inositol 1,4,5-trisphosphate receptor type 1 is responsible for a decreased endoplasmic-reticulum Ca2+ content in presenilin double knock-out cells. , 2006, Cell calcium.

[160]  Jie Shen,et al.  Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons , 2013, Proceedings of the National Academy of Sciences.

[161]  M. Mattson,et al.  Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease , 2011, Pharmacological Reviews.

[162]  F. LaFerla,et al.  Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2006.050593 Molecular Pathogenesis of Genetic and Inherited Diseases A Dynamic Relationship between Intracellular and Extracellular Pools of A� , 2022 .

[163]  J. Keizer,et al.  A single-pool inositol 1,4,5-trisphosphate-receptor-based model for agonist-stimulated oscillations in Ca2+ concentration. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[164]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[165]  T. Pozzan,et al.  Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia , 2005, Neurobiology of Disease.

[166]  Nicholas T. Carnevale,et al.  Simulation of networks of spiking neurons: A review of tools and strategies , 2006, Journal of Computational Neuroscience.

[167]  J. Watras,et al.  Inositol 1,4,5-Trisphosphate (InsP3) and Calcium Interact to Increase the Dynamic Range of InsP3 Receptor-dependent Calcium Signaling , 1997, The Journal of general physiology.

[168]  M. Kawato,et al.  Inositol 1,4,5-Trisphosphate-Dependent Ca2+ Threshold Dynamics Detect Spike Timing in Cerebellar Purkinje Cells , 2005, The Journal of Neuroscience.

[169]  Ata Akin,et al.  Modelling of calcium dynamics in brain energy metabolism and Alzheimer's disease , 2005, Comput. Biol. Chem..

[170]  S. Pimplikar,et al.  Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain , 2005, The Journal of cell biology.

[171]  D. Bennett,et al.  Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease , 2012, Neurobiology of Aging.

[172]  P. Smolen,et al.  Calcium dynamics in large neuronal models , 1998 .

[173]  Brian J. Bacskai,et al.  Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.

[174]  D. Alkon,et al.  Internal Ca 2 + mobilization is altered in fibroblasts from patients with Alzheimer disease , 2005 .

[175]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[176]  K. Davies,et al.  Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.

[177]  Colin W. Taylor,et al.  Dynamic regulation of IP3 receptor clustering and activity by IP3 , 2009, Channels.

[178]  P. Greengard,et al.  Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[179]  M. Bortolozzi,et al.  Presenilin 2 modulates endoplasmic reticulum (ER)–mitochondria interactions and Ca2+ cross-talk , 2011, Proceedings of the National Academy of Sciences.

[180]  P. Koulen,et al.  The cytosolic N-terminus of presenilin-1 potentiates mouse ryanodine receptor single channel activity. , 2008, The international journal of biochemistry & cell biology.

[181]  D. Westaway,et al.  Amyloid-β-(1-42) Increases Ryanodine Receptor-3 Expression and Function in Neurons of TgCRND8 Mice* , 2006, Journal of Biological Chemistry.

[182]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[183]  K. Yano,et al.  Dual sensitivity of sarcoplasmic/endoplasmic Ca2+-ATPase to cytosolic and endoplasmic reticulum Ca2+ as a mechanism of modulating cytosolic Ca2+ oscillations. , 2004, The Biochemical journal.

[184]  Hajime Takano,et al.  Suppression of InsP3 Receptor-Mediated Ca2+ Signaling Alleviates Mutant Presenilin-Linked Familial Alzheimer's Disease Pathogenesis , 2014, The Journal of Neuroscience.

[185]  Tiina Manninen,et al.  Effects of Transmitters and Amyloid-Beta Peptide on Calcium Signals in Rat Cortical Astrocytes: Fura-2AM Measurements and Stochastic Model Simulations , 2011, PloS one.

[186]  S. Ferreira,et al.  Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[187]  B. de Strooper,et al.  Role of Presenilins in Neuronal Calcium Homeostasis , 2010, The Journal of Neuroscience.

[188]  G. Hajnóczky,et al.  MAM: more than just a housekeeper. , 2009, Trends in cell biology.

[189]  Marc Cruts,et al.  Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.

[190]  P. Ghisdal,et al.  Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death , 2004, Journal of neurochemistry.

[191]  Jae Woong Lee,et al.  PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[192]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[193]  I. Bezprozvanny Presenilins and Calcium Signaling—Systems Biology to the Rescue , 2013, Science Signaling.

[194]  F. LaFerla,et al.  Enhanced Ryanodine Receptor Recruitment Contributes to Ca2+ Disruptions in Young, Adult, and Aged Alzheimer's Disease Mice , 2006, The Journal of Neuroscience.

[195]  Y. Auberson,et al.  Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N‐methyl‐D‐aspartate receptor in mature hippocampal cultures treated with amyloid‐β oligomers , 2012, Aging cell.

[196]  Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies , 2010 .

[197]  G. Dupont,et al.  The progression towards Alzheimer's disease described as a bistable switch arising from the positive loop between amyloids and Ca(2+). , 2013, Journal of theoretical biology.

[198]  E. Jazin,et al.  Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling , 2006, Neurobiology of Disease.